相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004-2010)
Hyun Seung Ban et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors
Kazuki Shimizu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Identification of HSP60 as a Primary Target of o-Carboranylphenoxyacetanilide, an HIF-1α Inhibitor
Hyun Seung Ban et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
In Vivo Imaging of HIF-Active Tumors by an Oxygen-Dependent Degradation Protein Probe with an Interchangeable Labeling System
Takahiro Kuchimaru et al.
PLOS ONE (2010)
1-[4-(N-Benzylamino)phenyl]-3-phenylurea derivatives as a new class of hypoxia-inducible factor-1α inhibitors
Masaharu Uno et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Selective Killing of Hypoxia-Inducible Factor-1-Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
Shinae Kizaka-Kondoh et al.
CLINICAL CANCER RESEARCH (2009)
Development of HIF-1 inhibitors for cancer therapy
Barbara Onnis et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226
Chun-Jen Chen et al.
BIOCHEMICAL PHARMACOLOGY (2008)
A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1α
Shan Hua Li et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A practical, metal-free synthesis of 1H-indazoles
Carla M. Counceller et al.
ORGANIC LETTERS (2008)
Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1
Nathaniel I. Martin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Targeting hypoxia cell signaling for cancer therapy
Giovanni Melillo
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia-inducible factors: central regulators of the tumor phenotype
John D. Gordan et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Suppression of hypoxia inducible factor-1α (HIF-1α) by YC-1 is dependent on murine double minute 2 (Mdm2)
Chi Keung Lau et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The design and synthesis of YC-1 analogues as probes for soluble guanylate cyclase
KW Hering et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
YC-1 [3-(5 '-hydroxymethyl-2 '-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9
YN Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential
Oleg V. Evgenov et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Versatile pharmacological actions of YC-1: anti-platelet to anticancer
YS Chun et al.
CANCER LETTERS (2004)
HIF-1 as a target for drug development
A Giaccia et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
YGI: A potential anticancer drug targeting hypoxia-inducible factor 1
EJ Yeo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Signal transduction to hypoxia-inducible factor 1
GL Semenza
BIOCHEMICAL PHARMACOLOGY (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Synthesis of 1-benzyl-3-(5′-hydroxymethyl-2′-furyl)indazole analogues as novel antiplatelet agents
FY Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells
YS Chun et al.
BIOCHEMICAL PHARMACOLOGY (2001)
NO-independent stimulators of soluble guanylate cyclase
A Straub et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
ME Cockman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
